Evidence map›Paper›PMID 30231161›Full record

ArticleRevista do Instituto de Medicina Tropical de Sao Paulo2018

Potential role of zinc in the visceromegaly regression and recovery of hematological parameters during treatment of visceral leishmaniasis in children from an endemic area.

Débora Cardozo Bonfim Carbone, Lourdes Zélia Garcia Zanoni, Fernanda Zanoni Cônsolo, Simone Camargo Sanches, Vanessa Quadros Dos Reis, Karla de Toledo Candido Muller, Cristiano Marcelo Espinola Carvalho, Maria Cláudia Silva

Open access · diamondAbstract read
In one paragraph

Article in Revista do Instituto de Medicina Tropical de Sao Paulo, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Débora Cardozo Bonfim CarbonePrograma de Pós-Graduação em Saúde e Desenvolvimento, Universidade Federal do Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Lourdes Zélia Garcia ZanoniPrograma de Pós-Graduação em Saúde e Desenvolvimento, Universidade Federal do Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Fernanda Zanoni CônsoloPrograma de Pós-Graduação em Saúde e Desenvolvimento, Universidade Federal do Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Simone Camargo SanchesRede Centro-Oeste de Pós-Graduação, Universidade Federal do Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Vanessa Quadros Dos ReisHospital Universitário Maria Aparecida Pedrossian, Universidade Federal do Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Karla de Toledo Candido MullerPrograma de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, Mato Grosso do Sul, Brazil.
Cristiano Marcelo Espinola CarvalhoPrograma de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, Mato Grosso do Sul, Brazil.
Maria Cláudia SilvaPrograma de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, Mato Grosso do Sul, Brazil.
Universidade Católica Dom Bosco · BRUniversidade Federal de Mato Grosso do Sul · BRHospital Universitário de Santa Maria · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leishmaniasis is a disease complex with various clinical symptoms caused by different species of parasites of the genus Leishmania. The visceral form of the disease, characterized by severe symptoms is fatal, if not treated. The high toxicity of current antileishmanial drugs and the need for long-term treatment make the therapy complicated, especially in a large number of infected children. Hence, the search for new therapies must be intensified. Oral administration of the trace element zinc has been considered in alternative treatments against different clinical forms of leishmaniasis. This study revealed that the administration of zinc in children with visceral leishmaniasis, during treatment with amphotericin B or glucantime, accelerates the regression of the spleen enlargement without interfering with the recovery of hematological parameters.

Indexed as

Dietary SupplementsAmphotericin BAntiprotozoal AgentsBiomarkersCase-Control StudiesChildChild, PreschoolEndemic DiseasesFemaleHumansInfantLeishmaniasis, VisceralLiverMaleMeglumineMeglumine AntimoniateAmphotericin BAntiprotozoal AgentsBiomarkersMeglumineMeglumine AntimoniateOrganometallic CompoundsZinc

Identifiers

PMID30231161
PMCPMC6169088
OpenAlexW2891570927

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.